Bridging the gap between islet allotransplantation and regulatory reform
Drug Discovery World
SEPTEMBER 26, 2024
Dr Rita Bottino Director of Islet Programs at Imagine Pharma, discusses the need for regulatory reform in islet allotransplantation for type 1 diabetes. Islet allotransplantation – the transplantation of isolated pancreatic islets from a deceased donor to a living recipient with type 1 diabetes – has emerged as a promising therapy for patients (..)
147 
Let's personalize your content